ALKS Stock Quote - Alkermes PLC Stock News, ResearchWarren Buffett Guru Investors

31.69 (1y: +91%)

Market Cap	4.04 B	P/E(ttm)
Enterprise Value	4.2 B	P/B	4.95

ALKS- NAS (USA)
Alkermes PLC

Currently 1/5

Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$31.69

1 Severe Warning Sign 3 Medium Warning Signs

Bookmark

Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score

Market Cap $M	4,039	Revenue $M	543	Net Margin (%)	-29.1	Z-Score	4.9
Enterprise Value $M	4,293	EPS $	-0.3	Operating Margin %	-22.6	F-Score	4
P/E(ttm))	0	Cash Flow Per Share $	0.0	Pre-tax Margin (%)	-29.3	Higher ROA y-y	N
Price/Book	5.0	10-y EBITDA Growth Rate %	0	Quick Ratio	4.0	Cash flow > Earnings	Y
Price/Sales	7.8	5-y EBITDA Growth Rate %	0	Current Ratio	5.3	Lower Leverage y-y	Y
Price/Cash Flow	725	y-y EBITDA Growth Rate %	0	ROA % (ttm)	-7.9	Higher Current Ratio y-y	Y
Dividend Yield %	0	Insider Buy (3m)	1	ROE % (ttm)	-13.3	Less Shares Outstanding y-y	N
Payout Ratio %	0	Shares Outstanding M	133	ROI % (ttm)	2.0	Gross Margin Increase y-y	N

Gurus Latest Trades with ALKS

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL

Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

Total Records: 11

Ticker	Guru	Date	Action	Impact	Price Range (Average)*	Current Price	Change from Average	Comment	Current Shares
ALKS	Vanguard Health Care Fund	2013-03-31	Add	0.04%	$18.52 - $23.81 ($21.87)	$ 31.69	45%	Add 47.24%	1,233,024
ALKS	Vanguard Health Care Fund	2012-03-31	Buy	0.07%	$16.14 - $19.5 ($16.48)	$ 31.69	92%	New holding, 787900 sh.	787,900
ALKS	John Burbank	2012-03-31	Sold Out	-0.23%	$16.14 - $19.5 ($16.48)	$ 31.69	92%	Sold Out	0
ALKS	Daniel Loeb	2010-06-30	Sold Out	-0.92%	$10.7 - $13.75 ($12.33)	$ 31.69	157%	Sold Out	0
ALKS	Daniel Loeb	2010-03-31	Buy	0.92%	$9.41 - $14.01 ($11.62)	$ 31.69	173%	New holding, 1000000 sh.	1,000,000
ALKS	George Soros	2010-03-31	Sold Out		$9.41 - $14.01 ($11.62)	$ 31.69	173%	Sold Out	0
ALKS	Jean-Marie Eveillard	2010-03-31	Sold Out	-0.01%	$9.41 - $14.01 ($11.62)	$ 31.69	173%	Sold Out	0
ALKS	George Soros	2009-12-31	Buy		$7.58 - $9.88 ($8.72)	$ 31.69	263%	New holding, 22800 sh.	22,800
ALKS	Daniel Loeb	2009-12-31	Sold Out	-0.37%	$7.58 - $9.88 ($8.72)	$ 31.69	263%	Sold Out	0
ALKS	Daniel Loeb	2009-09-30	Buy	0.37%	$8.75 - $11.65 ($10.13)	$ 31.69	213%	New holding, 500000 sh.	500,000
ALKS	Jean-Marie Eveillard	2009-09-30	Buy	0.01%	$8.75 - $11.65 ($10.13)	$ 31.69	213%	New holding, 100000 sh.	100,000
Real Time Picks are included for Premium Members only!!

*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Total Records: 11

ALKS is held by these Gurus:

Ticker	Guru Name	Portfolio Date*	Current Shares	% of Shares Outstanding	% of Total Assets Managed	Change from Last Holdings	Holding History
ALKS	Vanguard Health Care Fund	2013-03-31	1,233,024	0.93	0.12	+47.24%

Most recent portfolio changes are included for Premium Members only!

ALKS: Insider Buys/Sells

Click Here for All Insider Trades.

Insider	Position	Date	Trades	Shares	Trade Price ($)	Change (%)	Details
BLOOM FLOYD E	Director	2012-04-26	Buy	20,000	$17.59	80.16	view
HENWOOD GERALDINE	Director	2012-02-23	Sell	48,000	$17.29	83.29	view
FRATES JAMES M	SVP & CFO, Alkermes plc	2012-02-21	Sell	5,000	$18.25	73.64	view
Pugh Gordon G	SVP, COO & CRO, Alkermes, Inc.	2012-02-10	Sell	11,550	$18.06	75.47	view
BREYER ROBERT A	Director	2012-02-01	Sell	5,000	$18.99	66.88	view
FRATES JAMES M	SVP & CFO, Alkermes plc	2012-02-01	Sell	10,000	$18.97	67.05	view
POPS RICHARD F	Director and CEO, Alkermes plc	2012-02-01	Sell	60,000	$18.83	68.3	view
LANDINE MICHAEL J	SVP, Corp Dev., Alkermes, Inc.	2012-02-01	Sell	12,500	$18.95	67.23	view
Pugh Gordon G	SVP, COO & CRO, Alkermes, Inc.	2012-01-24	Sell	15,000	$17.65	79.55	view
BREYER ROBERT A	Director	2012-01-10	Sell	5,000	$18	76.06	view

Press Releases about ALKS:

Alkermes’ Corporate Presentation to be Webcast at Three... 19 Feb 2013
Alkermes to Host Conference Call to Discuss Financial... 24 Jan 2013
Alkermes’ Corporate Presentation to be Webcast at the 31st... 02 Jan 2013
Alkermes and Collaborators to Present Data from Three... 03 Dec 2012
Alkermes plc Reports Second Quarter Fiscal 2013 Financial... 01 Nov 2012

Quarterly/Annual Reports about ALKS:

10-Q - ALKERMES INC (0000874663) (Filer): (10-Q) 01 Aug 2011
10-K/A - ALKERMES INC (0000874663) (Filer): (10-K/A) 21 Jul 2011
10-K - ALKERMES INC (0000874663) (Filer): (10-K) 20 May 2011
10-Q - ALKERMES INC (0000874663) (Filer): (10-Q) 03 Feb 2011
10-Q - ALKERMES INC (0000874663) (Filer): (10-Q) 04 Nov 2010

News about ALKS:

Articles On GuruFocus.com

Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter Apr 30 2012

Weekly CEO Sells Highlight: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm Oct 09 2011

Alkermes Inc. Reports Operating Results (10-Q) Feb 03 2011

Weekly Guru Bargains Highlights: SKX, VRX, ALKS, DF, SVU Dec 05 2010

Alkermes Inc. Reports Operating Results (10-Q) Nov 04 2010

Alkermes Inc. Reports Operating Results (10-K) May 21 2010

Alkermes Inc. Reports Operating Results (10-Q) Feb 04 2010

Opportunistic Coat-tailing Jan 05 2010

Weekly Guru Bargains Highlights: Coinstar Inc, Fair Isaac Corp, Alkermes Inc, American International Dec 12 2009

Alkermes Inc. Reports Operating Results (10-Q) Nov 05 2009

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles